4 research outputs found
Next Generation Nanochitosan Applications in Animal Husbandry, Aquaculture and Food Conservation
Studies have identified the properties of enzymes, functionalized
molecules, and compounds in food industry applications as edible
coatings and encapsulations, that assure prolonged food quality and
standards. These molecules present benefits of longer shelf-life by
delayed deterioration and inhibition of the proliferation of spoilage and
mycotoxigenic microorganisms. However, challenges of reduced
nutrient levels, miniaturized size, and low chemical stability remain
concerning. Chitosan polymers naturally formed from the
deacetylation of shellfish shells and exoskeletons of aquatic
arthropods and crustaceans offer improved benefits when
functionalized into nanoparticles as nanochitosans. These
polysaccharides produced by the alkalescent deacetylation of chitin,
comprise a series of 2-deoxy-2 (acetylamino) glucose linked by ß-(1-
4) glycosidic linkages. This chapter considers the health impacts and
microbiological health hazards associated with animal feeds quality
and the enzyme immobilization potentials of nanochitosans in animalbased
food and feed packages. Thereafter, nanochitosan properties
and benefits are compared against traditional preservatives from
microbes and plants; with highlights on current challenges in the
application of nanochitosan for enzyme immobilization
Chapter 21 - Utilization of nanochitosan in the sterilization of ponds and water treatment for aquaculture
Water pollution constitutes the leading cause of infant mortality,
neonatal deformities, and shrinkage of man’s average life expectancy.
Pollutants come from point and nonpoint sources; and water pollution
arises from the discharge of wastewater containing undesirable
impurities used for domestic, agricultural, and industrial purposes.
More so, high nutrient and wastewater runoffs from fish production
systems contribute to the fouling and eutrophication of recipient water
bodies. Hence, aquaculture which is inextricably linked to the natural
environment is challenged by the dearth of appropriate water quantity
and quality, militating against fish, and fishery production.
Nanochitosans as polysaccharides produced by the alkalescent
deacetylation of chitin, comprise a series of 2-deoxy-2 (acetylamino)
glucose linked by ß-(1-4) glycosidic linkages. They are naturally
formed from the deacetylation of shellfish shells and exoskeletons of
aquatic arthropods and crustaceans. The unique attributes of chitin
confer a wide range of biotechnological applications on the polymer,
observed in flocculation as a wastewater treatment and purification
route initiated by chitosan. This chapter highlights nanochitosan properties of aquaculture relevance; and elucidates the purification
potentials of nanochitosan, compared to inorganic coagulants and
organic polymeric flocculants. Effects of chitosan on contaminants and
microorganisms, as well as applications in fish pathogens detection,
fish disease diagnosis, and control are discussed
Utilization of nanochitosan for enzyme immobilization of aquatic and animal-based food packages
Studies have identified the properties of enzymes, functionalized molecules, and compounds in food industry applications as edible coatings and encapsulations, that assure prolonged food quality and standards. These molecules present benefits of longer shelf-life by delayed deterioration and inhibition of the proliferation of spoilage and mycotoxigenic microorganisms. However, challenges of reduced nutrient levels, miniaturized size, and low chemical stability remain concerning. Chitosan polymers naturally formed from the deacetylation of shellfish shells and exoskeletons of aquatic arthropods and crustaceans offer improved benefits when functionalized into nanoparticles as nanochitosans. These polysaccharides produced by the alkalescent deacetylation of chitin, comprise a series of 2-deoxy-2 (acetylamino) glucose linked by ß-(1-4) glycosidic linkages. This chapter considers the health impacts and
Serum uric acid and left ventricular hypertrophy in hypertensive patients in Ado-Ekiti
Introduction: systemic hypertension is a foremost risk factor for cardiovascular morbidity and mortality. Its actions are manifested on organs like the brain, heart and kidneys. High serum uric acid (SUA) escalates cardiovascular vulnerability in patients with systemic hypertension.
Methods: a cross-sectional study was performed in 271 (178 females, 93 males) patients with systemic hypertension. Two hundred and seventy one healthy age and sex matched non-hypertensive persons obliged as controls. Left ventricular hypertrophy (LVH) was estimated by echocardiography. Blood samples were collected for measuring uric acid levels.
Results: mean SUA was significantly higher among the hypertensive patients (371±125μmol/L) than in the controls (269 ± 101.4μmol/L; p < 0.001), and the prevalence of hyperuricemia was 46.9% among the hypertensives and 11.1% among the controls (P < 0.001). Independent predictors of SUA were class of systemic hypertension, left ventricular mass index (LVMI), body mass index (BMI) and age. However, class of hypertension was the best independent predictor of SUA levels in the multivariate regression model (β = 0.597). Linear regression revealed SUA levels ≥ 430μmols/l as a predictor of stage 2 hypertension (F = 26.620, p = < 0.001). Among the hypertensive patients, LVH was present in 39.3% of those with hyperuricemia and in 28.0% of those with normal SUA levels (p = 0.003).
Conclusion: results indicate serum uric acid is positively correlated with hypertension and a reliable indicator of LVH in study population